Stocks
Ionis Pharmaceuticals (IONS) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 36.6% | -14.8% | -0.03% | -38.8% | -29.2% | -31.5% | ||
| Changes by years, y/y, % | +47pp | -51pp | +15pp | -39pp | +10pp | +23.3% | |||
Ionis Pharmaceuticals. EBITDA margin, %
Ionis Pharmaceuticals. EBITDA margin, changes, pp
Ionis Pharmaceuticals (IONS) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -78.6% | 7.76% | -96.2% | -16.8% | -93.4% | -31.5% | |
| Changes by years, y/y, % | -47pp | +243pp | -22pp | +15pp | -15pp | |||
| Changes by quarters, q/q, % | -47pp | +86pp | -104pp | +79pp | -77pp | |||
